Skip to main content
Have a personal or library account? Click to login
Genetic markers in oligodendroglial tumours Cover

Genetic markers in oligodendroglial tumours

Radiology and Oncology
Volume 44 (2010): Issue 1 (March 2010)
By: ,  ,   and    
Open Access
|Mar 2010
References

References

  1. Gilbert MR, Lang FF. Management of patients with low-grade gliomas.2007;: 1073-88.
    Open DOISearch in Google Scholar
  2. Strojnik T, Gornik-Kramberger K. [Stereotactic biopsy of brain tumours - Maribor experience with MHT stereotaxy system]. [Slovenian].2008;: 601-8.
    Search in Google Scholar
  3. Asthagiri AR, Pouratian N, Sherman J, Ahmed G, Shaffrey ME. Advances in brain tumor surgery.2007;: 975-1003. Engelhard HH, Stelea A, Mundt A. Oligodendroglioma and anaplastic oligodendroglioma: clinical features, treatment and prognosis.2003;: 443-56.
    Open DOISearch in Google Scholar
  4. Strojnik A. Search of the shortest regimen: fractionation of a fully isoeffective combination of hyperfractionated and hypofractionated treatment.2008;: 170-2.
    Open DOISearch in Google Scholar
  5. Heikal AA, Wachowicz K, Thomas SD, Fallone BG. A phantom to assess the accuracy of tumor delineation using MRSI.2008;: 232-9.
    Open DOISearch in Google Scholar
  6. Giampaoli S. Epidemiology of major age-related diseases in women compared to men.2000;: 93-105.
    Open DOISearch in Google Scholar
  7. Pytel P, Lukas RV. Update on diagnosic practice: tumors of the nervous system.2009;: 1062-77.
    Open DOISearch in Google Scholar
  8. van den Bent MJ, Reni M, Gatta G, Vecht C. Oligodendroglioma.2008;: 262-72.
    Open DOISearch in Google Scholar
  9. Siker ML, Chakravarti A, Mehta MP. Should concomitant and adjuvant treatment with temozolomide be used as standard therapy in patients with anaplastic glioma?2006;: 99-111.
    Open DOISearch in Google Scholar
  10. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, editors.Lyon 2007: WHO, IARC; 2007. p. 53-67.
    Open DOISearch in Google Scholar
  11. Ohgaki H. Epidemiology of brain tumors.2009;: 323-42.
    Open DOISearch in Google Scholar
  12. Ljubljana: Institute of Oncology Ljubljana, Cancer Registry of Slovenia; 2008.
    Search in Google Scholar
  13. Kachanov DY, Dobrenkov KV, Shamanskaya TV, Abdullaev RT, Inushkina EV, Savkova RF, et al. Solid tumors in young children in Moscow Region of Russian Federation.2008;: 39-44.
    Open DOISearch in Google Scholar
  14. Wrensch M, Fisher JL, Schwartzbaum JA, Bondy M, Berger M, Aldape KD. The molecular epidemiology of gliomas in adults.2005;: E5.
    Open DOISearch in Google Scholar
  15. Wrensch M, Minn Y, Chew T, Bondy M, Berger MS. Epidemiology of primary brain tumors: current concepts and review of the literature.2002;: 278-99.
    Open DOISearch in Google Scholar
  16. Hilton DA, Melling C. Genetic markers in teh assesment of intrinsic brain tumours.2004;: 83-92.
    Open DOISearch in Google Scholar
  17. Scelsi R. Epidemiology of cerebral gliomas.1984;: 1259-63.
    Search in Google Scholar
  18. Louis DN. Molecular pathology of malignant gliomas.2006;: 97-117.
    Open DOISearch in Google Scholar
  19. Wong ET, Hess KR, Gleason MJ, Jaeckle KA, Kyritsis AP, Prados MD, et al. Outcomes and prognostic factors in recurrent glioma patients enrolled onto phase II clinical trials.1999;: 2572-8.
    Open DOISearch in Google Scholar
  20. Engelhard HH, Stelea A, Cochran EJ. Oligodendroglioma: pathology and molecular biology.2002;: 111-7.
    Open DOISearch in Google Scholar
  21. Engelhard HH, Stelea A, Mundt A. Oligodendroglioma and anaplastic oligodendroglioma: clinical features, treatment, and prognosis.2003;: 443-56.
    Open DOISearch in Google Scholar
  22. Figarella-Branger D, Colin C, Coulibaly B, Quilichini B, Maues De Paula A, Fernandez C, et al. Histological and molecular classification of gliomas.2008;: 505-15.
    Open DOISearch in Google Scholar
  23. Zustovich F, Della Puppa A, Scienza R, Anselmi P, Furlan C, Cartei G. Metastatic oligodendrogliomas: a review of the literature and case report.2008;: 699-703.
    Open DOISearch in Google Scholar
  24. Volavsek M, Lamovec J, Popović M. Extraneural metastases of anaplastic oligodendroglial tumors.2009;: 502-7.
    Open DOISearch in Google Scholar
  25. Bromberg JE, van den Bent MJ. Oligodendrogliomas: molecular biology and treatment.2009;: 155-63.
    Open DOISearch in Google Scholar
  26. van den Bent MJ. Diagnosis and management of oligodendroglioma.2004;: 645-52.
    Open DOISearch in Google Scholar
  27. Franko A, Holjar-Erlic I, Miletic D. Lateral ventricle epidermoid.2008;: 66-8.
    Open DOISearch in Google Scholar
  28. Bisof V, Juretic A, Saric N, Melada A, Perkovic Z, Rados M, et al. Pituitary metastasis of renal cell carcinoma: a case report.2008;: 225-31.
    Open DOISearch in Google Scholar
  29. Liigant A, Haldre S, Oun A, Linnamägi U, Saar A, Asser T, et al. Seizure disorders in patients with brain tumors.2001;: 46-51.
    Open DOISearch in Google Scholar
  30. Engelhard HH. Current diagnosis and treatment of oligodendroglioma.2002;: E2.
    Open DOISearch in Google Scholar
  31. Celli P, Nofrone I, Palma L, Cantore G, Fortuna A. Cerebral oligodendroglioma: prognostic factors and life history.1994;: 1018-35.
    Open DOISearch in Google Scholar
  32. Burton EC, Prados MD. Malignant gliomas.2000;: 459-68.
    Open DOISearch in Google Scholar
  33. Gannett DE, Wisbeck WM, Silbergeld DL, Berger MS. The role of post-operative irradiation in the treatment of oligodendroglioma.1994;: 567-73.
    Open DOISearch in Google Scholar
  34. Paleologos NA, Cairncross JG. Treatment of oligodendroglioma: an update.1999;: 61-8.
    Open DOISearch in Google Scholar
  35. Bullard DE, Rawlings CE 3rd, Phillips B, Cox EB, Schold SC Jr, Burger P, et al. Oligodendroglioma. An analysis of the value of radiation therapy.1987;: 2179-88.
    Open DOISearch in Google Scholar
  36. van den Bent MJ. Chemotherapy of oligodendroglial tumours: current developments.2000;: 108-18.
    Search in Google Scholar
  37. van den Bent MJ. New perspectives for the diagnosis and treatment of oligodendrogliomav.2001;: 348-56.
    Open DOISearch in Google Scholar
  38. Medical Research Council Brain Tumor Working Party. Randomized trial of procarbazine, lomustine, and vincristine in the adjuvant treatment of high-grade astrocytoma: a Medical Research Council trial.2001;: 509-18.
    Open DOISearch in Google Scholar
  39. Soffietti R. Chemotherapy of anaplastic oligodendroglial tumours.2004;: 295-306.
    Open DOISearch in Google Scholar
  40. Yung WK, Prados MD, Yaya-Tur R, Rosenfeld SS, Brada M, Friedman HS, et al. Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. Temodal Brain Tumor Group.1999;: 2762-71.
    Open DOISearch in Google Scholar
  41. Michotte A, Chaskis C, Sadones J, Veld PI, Neyns B. Primary leptomeningeal anaplastic oligodendroglioma with a 1p36-19q13 deletion: Report of a unique case successfully treated with Temozolomide.2009;: 267-70.
    Open DOISearch in Google Scholar
  42. Morrison T, Bilbao JM, Yang G, Perry JR. Bony metastases of anaplastic oligodendroglioma respond to temozolomide.2004;: 102-8.
    Open DOISearch in Google Scholar
  43. van den Bent MJ. Anaplastic oligodendroglioma and oligoastrocytoma.2007;: 1089-109.
    Open DOISearch in Google Scholar
  44. Buckner JC, Reid JM, Wright K, Kaufmann SH, Erlichman C, Ames M, et al. Irinotecan in the treatment of glioma patients: current and future studies of the North Central Cancer Treatment Group.2003;: 2352-8.
    Open DOISearch in Google Scholar
  45. Soffietti R, Nobile M, Rudà R, Borgognone M, Costanza A, Laguzzi E, et al. Second-line treatment with carboplatin for recurrent or progressive oligodendroglial tumors after PCV (procarbazine, lomustine, and vincristine) chemotherapy: a phase II study.2004;: 807-13.
    Open DOISearch in Google Scholar
  46. Chamberlain MC, Johnston S. Bevacizumab for recurrent alkylator-refractory anaplastic oligodendroglioma.2009;: 1734-43.
    Open DOISearch in Google Scholar
  47. Gadji M, Fortin D, Tsanaclis AM, Drouin R. Is the 1p/19q deletion a diagnostic marker of oligodendrogliomas?2009;: 12-22.
    Open DOISearch in Google Scholar
  48. Stupp R, Hegi ME. Neuro-oncology: oligodendroglioma and molecular markers.2007;: 10-2.
    Open DOISearch in Google Scholar
  49. Ino Y, Betensky RA, Zlatescu MC, Sasaki H, Macdonald DR, Stemmer-Rachamimov AO, et al. Molecular subtypes of anaplastic oligodendroglioma: implications for patient management at diagnosis.2001;: 839-45.
    Search in Google Scholar
  50. Mueller W, Hartmann C, Hoffmann A, Lanksch W, Kiwit J, Tonn J, et al. Genetic signature of oligoastrocytomas correlates with tumor location and denotes distinct molecular subsets.2002;: 313-9.
    Open DOISearch in Google Scholar
  51. Ducray F, Idbaih A, de Reyniès A, Bièche I, Thillet J, Mokhtari K, et al. Anaplastic oligodendrogliomas with 1p19q codeletion have a proneural gene expression profile.2008;: 41.
    Open DOISearch in Google Scholar
  52. Riemenschneider MJ, Koy TH, Reifenberger G. Expression of oligodendrocyte lineage genes in oligodendroglial and astrocytic gliomas.2004;: 277-82.
    Open DOISearch in Google Scholar
  53. Li H, Lu Y, Smith HK, Richardson WD. Olig1 and Sox10 interact synergistically to drive myelin basic protein transcription in oligodendrocytes.2007;: 14375-82.
    Open DOISearch in Google Scholar
  54. Aldape K, Burger PC, Perry A. Clinicopathologic aspects of 1p/19q loss and the diagnosis of oligodendroglioma.2007;: 242-51.
    Open DOISearch in Google Scholar
  55. Glioma meta-analysis trialists group. Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials.2002;: 1011-8.
    Open DOISearch in Google Scholar
  56. van den Bent MJ, Carpentier AF, Brandes AA, Sanson M, Taphoorn MJ, Bernsen HJ, et al. Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: a randomized European Organisation for Research and Treatment of Cancer phase III trial.2006;: 2715-22.
    Open DOISearch in Google Scholar
  57. Brandes AA, Tosoni A, Cavallo G, Reni M, Franceschi E, Bonaldi L, et al. Correlations between O6-methylguanine DNA methyltransferase promoter methylation status, 1p and 19q deletions, and response to temozolomide in anaplastic and recurrent oligodendroglioma: a prospective GICNO study.2006;: 4746-53.
    Open DOISearch in Google Scholar
  58. Idbaih A, Omuro A, Ducray F, Hoang-Xuan K. Molecular genetic markers as predictors of response to chemotherapy in gliomas.2007;: 606-11.
    Open DOISearch in Google Scholar
  59. Fontaine D, Vandenbos F, Lebrun C, Paquis V, Frenay M. Diagnostic and prognostic values of 1p and 19q deletions in adult gliomas: critical review of the literature and implications in daily clinical practice.2008;: 595-604.
    Open DOISearch in Google Scholar
  60. Sonabend AM, Lesniak MS. Oligodendrogliomas: clinical significance of 1p and 19q chromosomal deletions.2005;: S25-32.
    Open DOISearch in Google Scholar
  61. Cankovic M, Mikkelsen T, Rosenblum ML, Zarbo RJ. A simplified laboratory validated assay for MGMT promoter hypermethylation analysis of glioma specimens from formalin-fixed paraffin-embedded tissue.2007;: 392-7.
    Open DOISearch in Google Scholar
  62. Mueller WC, von Deimling A. Gene regulation by methylation.2009;: 217-39.
    Open DOISearch in Google Scholar
  63. Norden AD, Wen PY. Glioma therapy in adults.2006;: 279-92.
    Open DOISearch in Google Scholar
DOI: https://doi.org/10.2478/v10019-010-0007-y | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Journal RSS Feed
Language: English
Page range: 13 - 18
Published on: Mar 18, 2010
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
oligodendroglioma,
genetic markers,
chemotherapy,
prognosis
Related subjects:
Medicine,
Clinical medicine,
Radiology

© 2010 Tomaz Velnar, Uros Smrdel, Mara Popovic, Gorazd Bunc, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons License.

Volume 44 (2010): Issue 1 (March 2010)
Previous article
Next article